Radiation recall myositis caused by pazopanib in a patient with refractory osteosarcoma

Pediatr Blood Cancer. 2021 Sep;68(9):e29147. doi: 10.1002/pbc.29147. Epub 2021 Jun 14.

Authors

Takuya Kosaka¹, Megumi Uto¹, Shinya Hiraoka¹, Itaru Kato², Katsutsugu Umeda², Hidefumi Hiramatsu², Akio Sakamoto³, Junko Takita², Takashi Mizowaki¹

Affiliations

¹ Department of Radiation Oncology and Image-Applied Therapy, Kyoto University, Kyoto, Japan.
² Pediatrics, Kyoto University, Kyoto, Japan.
³ Orthopaedic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

PMID: 34125491
DOI: 10.1002/pbc.29147

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Humans
Indazoles / adverse effects*
Myositis* / chemically induced
Osteosarcoma* / drug therapy
Pyrimidines / adverse effects*
Sulfonamides / adverse effects*

Substances

Indazoles
Pyrimidines
Sulfonamides
pazopanib